GeneOnline

U.S. National Library of Medicine Updates Clinical Documentation for Adasuve Inhalation Powder

The U.S. National Library of Medicine updated its clinical documentation for Adasuve (loxapine) inhalation powder on October 5, 2026. The medication, manufactured by Alexza Pharmaceuticals, Inc., ...
FT Markets

Insmed Announces CFO Transition

As Insmed continues to build on its operational excellence and momentum, the Company reaffirms its full-year 2026 financial guidance of revenue in the range of $1.25 billion to $1.40 billion for ...
note

その他の特定の型の喘息又は気管支痙攣 Other specified forms of asthma or bronchospasm（疾患理解・診察準備）プロンプト

「その他の特定の型の喘息又は気管支痙攣（ICD-10 J45.8等）」は、一般的なアレルギー性・非アレルギー性喘息の標準分類には直接当てはまらないものの、特定の生理的メカニズムや物理的 ...
MarketScreener

Insmed Incorporated Receives Fda Priority Review for Supplemental New Drug Application for Arikayce Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Avium ...

Insmed Incorporated announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's Supplemental New Drug Application (sNDA) for review of ARIKAYCE (amikacin liposome inhalation ...